MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

NeoGenomics Company Profile (NYSE:NEO)

Consensus Ratings for NeoGenomics (NYSE:NEO) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $7.75 (29.82% upside)

Analysts' Ratings History for NeoGenomics (NYSE:NEO)
Show:
DateFirmActionRatingPrice TargetActions
7/24/2015BTIG ResearchReiterated RatingBuy$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/13/2015Roth CapitalBoost Price Target$7.00 -> $7.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/12/2015Roth CapitalReiterated RatingBuy$7.00 -> $7.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/9/2015BTIG ResearchReiterated RatingBuy$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/6/2015Roth CapitalReiterated RatingBuy$7.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/22/2015BTIG ResearchInitiated CoverageBuy$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/13/2015Roth CapitalSet Price TargetBuy$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha